Long Term Observation for Immunogenecity of Plasma-Derived Hepatitis B Vaccine and Supplementary Vaccination of Recombinant Vaccine in Infants
نویسندگان
چکیده
منابع مشابه
STUDY ON THE EF FICACY OF RECOMBINANT HEPATITIS B VACCINE IN IRANIAN INFANTS
In order to determine the efficacy of recombinant hepatitis B vaccine in Iranian infants, we analyzed the efficacy of a recombinant hepatitis B vaccine in 115 infants aged 12-24 months born to HBsAg negative mothers who received three doses of HBV Antibody to hepatitis B surface antigen (anti-HBs) was checked after the third dose of the vaccine, 94.8% of the infants had developed protective...
متن کاملEffect of Sucrose 30% on Hepatitis B Vaccine Injection Pain Relief in Full Term Infants
Background and Objectives: Several studies have shown that sucrose intake results in pain relief during painful procedures among neonates. The effect of sucrose intake on intramuscular injection pain have less been studied. The aim of this study was to assess the effect of oral sucrose 30% on pain relief of Hepatitis B vaccine injection in full-term infants. Materials and Methods: In this tripl...
متن کاملHepatitis B vaccine immunogenicity in Kerman 12 months infants
Introduction: Infection with HBV is the most common chronic viral infection and mortality in children. Prevention of this infection with vaccination is vital. This study was done to compare the antibody level in post hepatitis B vaccination in children with 12 months age. Materials and Methods:This descriptive study was carreid out on healthy 120 children ...
متن کاملA Quick and Simple Polarographic Method for Aluminum Measurement in Recombinant Hepatitis B Vaccine
Abstract Background and Objective: Aluminum salts are among the most common useful additive compounds in preparation of human and animal vaccines. Aluminum phosphate and aluminum hydroxide are two additives that show good immunoadjuvant effects with many antigens. Aluminum-containing vaccines lead to a better and longer immune response compared to adjuv...
متن کاملLong-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.
Neonates of hepatitis B surface antigen (HBsAg) positive and hepatitis B encoded antigen (HBeAg) positive mothers received 10 micrograms of recombinant hepatitis B vaccine at months 0, 1, 6, or 0, 1, 2, 12, with or without immunoglobulin at birth, and were followed up to the age of 8 years for HBsAg, anti-HBc, and anti-HBs. Some were boosted at month 60. The overall vaccine protection at month ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Japanese Association for Infectious Diseases
سال: 1988
ISSN: 1884-569X,0387-5911
DOI: 10.11150/kansenshogakuzasshi1970.62.349